机构地区:[1]河北省邯郸市第一医院病理科,河北邯郸056002
出 处:《实用医院临床杂志》2025年第2期140-144,共5页Practical Journal of Clinical Medicine
基 金:河北省医学科学研究重点课题计划(编号:20181641)。
摘 要:目的探讨程序性死亡因子配体-1(PD-L1)、赖氨酸甲基转移酶2D(KMT2D)在原发性食管基底细胞样鳞状细胞癌(BSCC)组织中的表达及与患者预后的相关性。方法选取2015年1月至2019年1月我院收治的原发性食管BSCC患者47例,检测患者癌组织及癌旁组织中的PD-L1、KMT2D表达情况,并分析其与临床病理特征和预后的关系,用Kaplan-Meier法进行生存分析,并进行COX多因素分析影响患者预后的危险因素。结果PD-L1、KMT2D在原发性食管BSCC癌组织中的表达率均显著高于癌旁组织(P<0.05)。PD-L1和KMT2D高表达组与低表达组患者的浸润深度、临床分期和淋巴结转移比较,差异有统计学意义(P<0.05),而在性别、年龄、肿瘤大小、分化程度和肿瘤位置方面的差异无统计学意义(P<0.05)。原发性食管BSCC患者PD-L1与KMT2D表达呈正相关(P<0.01)。生存分析结果表明,PD-L1高表达组和PD-L1低表达组5年总生存率分别为12.5%(2/16)、41.9%(13/31),两组间累积总生存率差异有统计学意义(P<0.05);KMT2D高表达组和KMT2D低表达组5年总生存率分别为17.2%(5/29)、55.6%(10/18),累积总生存率差异有统计学意义(P<0.05)。COX多元回归分析显示,肿瘤分期为III~IV期、浸润深度为T4、存在淋巴结转移、PD-L1高表达及KMT2D高表达为影响患者预后的独立危险因素(P<0.05)。结论PD-L1、KMT2D高表达与原发性食管BSCC患者预后不良有密切关系,有望成为食管BSCC预后和诊断的标志物。Objective To investigate the expression of programmed death factor ligand-1(PD-L1)and lysine methyltransferase 2D(KMT2D)in primary basaloid squamous cell carcinoma of the esophagus(BSCC)and their correlation with prognosis of patients.Methods Forty-seven patients with BSCC treated in our hospital from January 2015 to January 2019 were selected.PD-L1 and KMT2D expression in cancerous and adjacent tissues were detected.The correlation between these expressions and clinicopathological features was analyzed.Kaplan-Meier method was used to analyze the survival.COX univariate and multivariate analysis was used to analyze the influencing factors for prognosis of the patients.Results The expressions of PD-L1 and KMT2D in cancer tissues of primary esophageal BSCC were significantly higher than those in para-cancer tissues(P<0.05).There were statistically significant differences in depth of invasion,clinical stage and lymph node metastasis between high and low expression groups of PD-L1 and KMT2D(P<0.05).There was no significant difference in gender,age,tumor size,tumor location and differentiation degree(P>0.05).There was a positive correlation between PD-L1 and KMT2D expression in primary esophageal BSCC patients(P<0.01).Survival analysis results showed that the 5-year overall survival rates of the PD-L1 high expression group and PD-L1 low expression group were 12.5%(2/16)and 41.9%(13/31),respectively.The difference of cumulative overall survival rates between the two groups was significance(P<0.05).The 5-year overall survival rates of the KMT2D high-expression group and the KMT2D low-expression group were 17.2%(5/29)and 55.6%(10/18),respectively.The difference in cumulative overall survival rate between the two groups was statistically significant(P<0.05).COX multivariate regression analysis identified that T4 invasion depth,III to IV tumor stage,lymph node metastasis,high expression of PD-L1,and high expression of KMT2D were independent risk factors affecting the prognosis of patients with primary esophageal BSCC(P<0.0
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...